Related Experiment Video
Updated: May 17, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Occult Hepatitis B (OBH) in Clinical Settings
Seyed Moayed Alavian1, Seyed Mohammad Miri, F Blaine Hollinger
1Baqiyatallah Research Center for Gastroenterology and Liver Disease, Baqiyatallah University of Medical Sciences, Tehran, IR Iran.
Occult hepatitis B (OHB) involves persistent hepatitis B virus (HBV) DNA in HBsAg-negative individuals. Its clinical relevance, pathogenesis, and impact on liver disease and cancer remain largely unknown, necessitating improved diagnostics and monitoring.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Occult hepatitis B (OHB) is defined by persistent hepatitis B virus (HBV) DNA in hepatitis B surface antigen (HBsAg)-negative individuals.
- This entity represents a recently recognized challenge in HBV infection management.
- OHB is increasingly identified across diverse patient populations and clinical scenarios.
Purpose of the Study:
- To review current hypotheses regarding the clinical significance of OHB.
- To update knowledge on the classification of OHB in various clinical settings.
- To summarize the existing understanding of this cryptic HBV infection.
Main Methods:
- Literature review of proposed hypotheses and classifications of OHB.
- Analysis of OHB prevalence in different patient groups, including those with viral co-infections, chronic HBV carriers, dialysis patients, and transplant recipients.
- Identification of special clinical settings where OHB may occur.
Main Results:
- The precise prevalence, pathogenesis, and clinical impact of OHB are not yet fully elucidated.
- The role of OHB in liver disease progression and hepatocellular carcinoma development is unknown.
- OHB can be detected in various populations, including those with HIV, HCV, chronic HBV, and in transplant and dialysis patients.
Conclusions:
- Effective control of HBV transmission via cryptic infections requires monitoring individuals with positive anti-HBc antibodies.
- Widespread HBV vaccination programs are crucial for reducing transmission.
- Advancements in diagnostic tools are essential for better detection and management of OHB.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease IV: Clinical Manifestations
